Ideaya Biosciences vs Puma Biotechnology
Ideaya Biosciences and Puma Biotechnology are similar in size: $219m and $228m of revenue in their latest fiscal years. Ideaya Biosciences grew faster (3024.4% against -0.9%). Puma Biotechnology kept more of each dollar of sales as profit: a net margin of 13.6% against -52.0%. Ideaya Biosciences carries less debt relative to equity (0.0% against 17.4%).
| Latest fiscal year | Ideaya BiosciencesIDYA, 2025 | Puma BiotechnologyPBYI, 2025 |
|---|---|---|
| Revenue | $219m | $228m |
| Revenue growth | 3024.4% | -0.9% |
| Net income | −$114m | $31.1m |
| Operating margin | -72.8% | 16.3% |
| Net margin | -52.0% | 13.6% |
| Return on equity | -10.9% | 28.0% |
| Free cash flow | −$73.5m | $41.7m |
| Cash | $113m | $29.6m |
| Total debt | $0 | $22.7m |
| Debt to equity | 0.0% | 17.4% |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | — | — |
| Employees | 145 | 179 |
| Market value | $3.02bn | $521m |
| Price vs our value range | — | Below our value range |
| Moat score | — | 47 (Moderate) |
| Insider trades, 12 months | 1 buys, 3 sales | 0 buys, 17 sales |